84 related articles for article (PubMed ID: 17278710)
21. Significant prevalence of antibodies reacting with simian virus 40 mimotopes in sera from patients affected by glioblastoma multiforme.
Mazzoni E; Gerosa M; Lupidi F; Corallini A; Taronna AP; D'Agostino A; Bovenzi M; Ruggeri G; Casali F; Rotondo JC; Rezza G; Barbanti-Brodano G; Tognon M; Martini F
Neuro Oncol; 2014 Apr; 16(4):513-9. PubMed ID: 24305701
[TBL] [Abstract][Full Text] [Related]
22. MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.
Aquino D; Gioppo A; Finocchiaro G; Bruzzone MG; Cuccarini V
J Immunol Res; 2017; 2017():5813951. PubMed ID: 28512646
[TBL] [Abstract][Full Text] [Related]
23. Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials.
Lieberman F
F1000Res; 2017; 6():1892. PubMed ID: 29263783
[TBL] [Abstract][Full Text] [Related]
24. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment.
Hanif F; Muzaffar K; Perveen K; Malhi SM; Simjee ShU
Asian Pac J Cancer Prev; 2017 Jan; 18(1):3-9. PubMed ID: 28239999
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy for malignant glioma.
Okura H; Smith CA; Rutka JT
Mol Cell Ther; 2014; 2():21. PubMed ID: 26056588
[TBL] [Abstract][Full Text] [Related]
26. New phase therapeutic pursuits for targeted drug delivery in glioblastoma multiforme.
Singh M; Jindal D; Agarwal V; Pathak D; Sharma M; Pancham P; Mani S; Rachana
Explor Target Antitumor Ther; 2022; 3(6):866-888. PubMed ID: 36654821
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response.
Dejaegher J; Van Gool S; De Vleeschouwer S
Immunotargets Ther; 2014; 3():55-66. PubMed ID: 27471700
[TBL] [Abstract][Full Text] [Related]
28. Cytomegalovirus as a novel target for immunotherapy of glioblastoma multiforme.
Schuessler A; Walker DG; Khanna R
Front Oncol; 2014; 4():275. PubMed ID: 25340042
[TBL] [Abstract][Full Text] [Related]
29. Targeted Glioma Therapy-Clinical Trials and Future Directions.
Shikalov A; Koman I; Kogan NM
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258110
[TBL] [Abstract][Full Text] [Related]
30. Case presentation - A five-year survival of the patient with glioblastoma brain tumor.
Urbańczyk H; Strączyńska-Niemiec A; Głowacki G; Lange D; Miszczyk L
Rep Pract Oncol Radiother; 2014 Sep; 19(5):347-51. PubMed ID: 25184061
[TBL] [Abstract][Full Text] [Related]
31. Glioblastoma Treatments: An Account of Recent Industrial Developments.
Alphandéry E
Front Pharmacol; 2018; 9():879. PubMed ID: 30271342
[TBL] [Abstract][Full Text] [Related]
32. Cerebellar giant cell glioblastoma multiforme in an adult.
Mishra SS; Behera SK; Dhir MK; Senapati SB
J Neurosci Rural Pract; 2014 Jul; 5(3):295-7. PubMed ID: 25002780
[TBL] [Abstract][Full Text] [Related]
33. Bone Metastasis From Glioblastoma Multiforme: A Case Report.
Zapata Laguado M; Baez JM; Luna A; Mantilla C; Palencia M
Cureus; 2022 May; 14(5):e25464. PubMed ID: 35800795
[TBL] [Abstract][Full Text] [Related]
34. Sexual dimorphism of the immune system predicts clinical outcomes in glioblastoma immunotherapy: A systematic review and meta-analysis.
Shireman JM; Ammanuel S; Eickhoff JC; Dey M
Neurooncol Adv; 2022; 4(1):vdac082. PubMed ID: 35821678
[TBL] [Abstract][Full Text] [Related]
35. Personalized medicine for gliomas.
Ene CI; Holland EC
Surg Neurol Int; 2015; 6(Suppl 1):S89-95. PubMed ID: 25722938
[TBL] [Abstract][Full Text] [Related]
36. Analysis of factors leading to early termination in glioblastoma-related clinical trials.
Shah HA; Mishra A; Gouzoulis MJ; Ben-Shalom N; D'Amico RS
J Neurooncol; 2022 Jul; 158(3):489-495. PubMed ID: 35648307
[TBL] [Abstract][Full Text] [Related]
37. Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine.
Takashima S; Oka Y; Fujiki F; Morimoto S; Nakajima H; Nakae Y; Nakata J; Nishida S; Hosen N; Tatsumi N; Mizuguchi K; Hashimoto N; Oji Y; Tsuboi A; Kumanogoh A; Sugiyama H
Future Sci OA; 2016 Dec; 2(4):FSO96. PubMed ID: 28116121
[TBL] [Abstract][Full Text] [Related]
38. Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies.
Sprenger T; Schirrmacher V; Stücker W; van Gool SW
Expert Rev Anticancer Ther; 2020 Aug; 20(8):639-646. PubMed ID: 32600076
[TBL] [Abstract][Full Text] [Related]
39. A husband and a wife with simultaneous presentation of glioblastoma multiforme: a case report.
Roviello G; Petrioli R; Cerase A; Marsili S; Miracco C; Rubino G; Tini P
Case Rep Oncol; 2013; 6(3):538-43. PubMed ID: 24348390
[TBL] [Abstract][Full Text] [Related]
40. Metformin as Potential Therapy for High-Grade Glioma.
Mazurek M; Litak J; Kamieniak P; Kulesza B; Jonak K; Baj J; Grochowski C
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31952173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
